272 related articles for article (PubMed ID: 27683014)
21. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A
Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884
[TBL] [Abstract][Full Text] [Related]
22. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
[TBL] [Abstract][Full Text] [Related]
23. The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers.
Kennedy DP; McRobb FM; Leonhardt SA; Purdy M; Figler H; Marshall MA; Chordia M; Figler R; Linden J; Abagyan R; Yeager M
Mol Pharmacol; 2014 Feb; 85(2):301-9. PubMed ID: 24217444
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.
Valant C; Aurelio L; Devine SM; Ashton TD; White JM; Sexton PM; Christopoulos A; Scammells PJ
J Med Chem; 2012 Mar; 55(5):2367-75. PubMed ID: 22315963
[TBL] [Abstract][Full Text] [Related]
25. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
[TBL] [Abstract][Full Text] [Related]
26. Role of extracellular cysteine residues in the adenosine A2A receptor.
De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
[TBL] [Abstract][Full Text] [Related]
27. Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.
Conner M; Hawtin SR; Simms J; Wootten D; Lawson Z; Conner AC; Parslow RA; Wheatley M
J Biol Chem; 2007 Jun; 282(24):17405-12. PubMed ID: 17403667
[TBL] [Abstract][Full Text] [Related]
28. Understanding the molecular functions of the second extracellular loop (ECL2) of the calcitonin gene-related peptide (CGRP) receptor using a comprehensive mutagenesis approach.
Woolley MJ; Simms J; Mobarec JC; Reynolds CA; Poyner DR; Conner AC
Mol Cell Endocrinol; 2017 Oct; 454():39-49. PubMed ID: 28572046
[TBL] [Abstract][Full Text] [Related]
29. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
Dong M; Lam PC; Orry A; Sexton PM; Christopoulos A; Abagyan R; Miller LJ
J Biol Chem; 2016 Mar; 291(10):5172-84. PubMed ID: 26740626
[TBL] [Abstract][Full Text] [Related]
30. Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.
Lu D; Yan H; Othman T; Turner CP; Woolf T; Rivkees SA
Biochem J; 2004 Jan; 377(Pt 1):51-9. PubMed ID: 12974671
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
[TBL] [Abstract][Full Text] [Related]
32. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
Heitman LH; Mulder-Krieger T; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Dalpiaz A; IJzerman AP
Br J Pharmacol; 2006 Mar; 147(5):533-41. PubMed ID: 16444290
[TBL] [Abstract][Full Text] [Related]
33. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
[TBL] [Abstract][Full Text] [Related]
34. A Structure-Activity Relationship Study of Bitopic N
Aurelio L; Baltos JA; Ford L; Nguyen ATN; Jörg M; Devine SM; Valant C; White PJ; Christopoulos A; May LT; Scammells PJ
J Med Chem; 2018 Mar; 61(5):2087-2103. PubMed ID: 29446948
[TBL] [Abstract][Full Text] [Related]
35. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
36. Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression.
Hawtin SR; Simms J; Conner M; Lawson Z; Parslow RA; Trim J; Sheppard A; Wheatley M
J Biol Chem; 2006 Dec; 281(50):38478-88. PubMed ID: 16990262
[TBL] [Abstract][Full Text] [Related]
37. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
[TBL] [Abstract][Full Text] [Related]
38. Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor.
Wootten D; Reynolds CA; Smith KJ; Mobarec JC; Furness SG; Miller LJ; Christopoulos A; Sexton PM
Biochem Pharmacol; 2016 Oct; 118():68-87. PubMed ID: 27569426
[TBL] [Abstract][Full Text] [Related]
39. Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
Forfar R; Lu ZL
J Biol Chem; 2011 Oct; 286(40):34617-26. PubMed ID: 21832286
[TBL] [Abstract][Full Text] [Related]
40. New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations.
Bolcato G; Bissaro M; Deganutti G; Sturlese M; Moro S
Biomolecules; 2020 May; 10(5):. PubMed ID: 32392873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
